Drug Screening Market Outlook 2022: Big Changes to Have Big Boom
Jan 25, 2024LUPKYNIS® Achieved Significantly Higher Renal Response in Lupus Nephritis Patients with High Proteinuria Compared to Patients Treated with MMF and Low Dose Steroids Alone
Jan 17, 2024Beckman Coulter Diagnostics announces global launch of immunoassay analyzer
Jan 10, 2024Week in Review: Quest on detecting dementia
Jan 02, 2024HUMAN Diagnostics to Showcase Innovative Products at the 2023 AACC Clinical Lab Expo
Dec 26, 2023-
Drug Screening Market Outlook 2022: Big Changes to Have Big Boom
The Latest Released Global Drug Screening market study has evaluated the future
-
LUPKYNIS® Achieved Significantly Higher Renal Response in Lupus Nephritis Patients with High Proteinuria Compared to Patients Treated with MMF and Low Dose Steroids Alone
$34.4 million in net revenue for the first quarter of 2023; an increase of 59%
-
Beckman Coulter Diagnostics announces global launch of immunoassay analyzer
Beckman Coulter Diagnostics on Monday launched the DxI 9000 Access Immunoassay
-
Week in Review: Quest on detecting dementia
Dear LabPulse.com reader: Testing industry giants continue to purchase strategic
-
HUMAN Diagnostics to Showcase Innovative Products at the 2023 AACC Clinical Lab Expo
(PresseBox) (Wiesbaden, 06.06.2023)
-
Grain Temperature Analyzer Market Size, Share, Growth, Trends And Demand 2023 To 2029
The market report Grain Temperature Analyzer Market offers a thorough
-
Beta
Communications Medicine
-
RedShift BioAnalytics Launches HaLCon™ Analyzer, Providing Simple and Accurate On
News provided by 07 Jun, 2023, 15:58 ET Share this article RedShiftBio
-
New Technologies for Electrophoresis
Angelo DePalma is a freelance writer living in Newton, New Jersey. You can reach
-
Unwanted COVID
OCALA, Fla. — Residents across the area are getting COVID-19 tests that suddenly
-
A COVID Test Medicare Scam May Be a Trial Run for Further Fraud : Shots
From By Susan Jaffe Some older Americans got
-
One of Northeast Georgia's last remaining drive
As public health moves from COVID-19 response to recovery, the drive-thru